Adis International - USA Company Profile

News Articles [ 16 Associated News Articles listed on BioPortfolio]

New hope for survivors of stroke and traumatic brain injury

(Springer) A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumati...

Substandard, non-approved drugs put patients at risk

(Springer Science+Business Media ) The recent outbreak of meningitis in the US -- and the subsequent deaths of 15 individuals -- has renewed scrutiny on the contemporary practice of pharmacy compoundi...

Physicians urged to think twice before they prescribe compounded drugs

The recent outbreak of meningitis in the US-and the subsequent deaths of 15 individuals-has renewed scrutiny on the contemporary practice of pharmacy compounding. The risks to patients, and associated...

Single dose of etanercept can improve chronic neurological dysfunction from stroke or TBI

A new ground-breaking study about to be published in the Adis journal CNS Drugs provides clinical evidence that, for the first time, chronic neurological dysfunction from stroke or traumatic brain inj...

International Health IT Standards: A Closer Look at ONC Efforts

Last week, I highlighted the work ONC does with the international health IT community at a broad level.  Today, I’m going to do a “deeper dive” into some of the specifics.  It’s important to...

NEBOSH International Diploma and Certificate Programs Now Offered in the USA by the Only USA Based Accredited Provider - NEBOSH IOG February 18-22, 2013

Houston, Texas (PRWEB) January 09, 2013 OSHE Consultants , the only USA registered organization and an international provider of Safety and Health Courses, has been accredited to offer the NEBOSH...

Cromsource expands US presence by acquiring international CRO Pleiad

Cromsource, an international full service contract research organisation (CRO) has acquired Pleiad, an established international CRO with offices in the US (Cambridge, Massachusetts) and UK (Stirling,...

PHARMESIS INTERNATIONAL LTD.: RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING

Miscellaneous* Asterisks denote mandatory informationName of Announcer *PHARMESIS INTERNATIONAL LTD.Company Registration No.200309641EAnnouncement submitted on behalf ofPHARMESIS INTERNATIONAL LTD....

Drugs and Medications [ 423 Associated Drugs and Medications listed on BioPortfolio]

Pvp iodine prep pad [Professional Disposables International, Inc.]

Drug Facts

Sani professional brand sani-hands for kids [Profesional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Muscle and joint vanishing scent [LIFElabs, a Division of Atico International USA, INC.]

LIFElabs, a Division of Atico International USA, INC.

Sani-hands [Professional Disposables International, Inc.]

SANI PROFESSIONAL BRAND SANI-HANDS FOR KIDS INSTANT HAND SANITIZING WIPES

Pdi sani-hands for kids [Professional Disposables International, Inc.]

PDI SANI-HANDS FOR KIDS ANTIMICROBIAL ALCOHOL GEL HAND WIPES

PubMed Articles [ 40 Associated PubMed Articles listed on BioPortfolio]

Linaclotide: first global approval.

Linaclotide is a once-daily, orally administered, first-in-class agonist of guanylate cyclase-C that is minimally absorbed. It is being developed to treat gastrointestinal disorders by Ironwood Pharma...

Once-Daily Memantine : A Guide to its Use in Moderate to Severe Alzheimer's Disease in the EU.

In the EU, once-daily memantine 20 mg (Axura(®), Ebixa(®)) is an option for the management of patients with moderate to severe Alzheimer's disease (AD). In pooled clinical trials and studies in the...

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males†: Profile Report.

Lixisenatide: First Global Approval.

The selective once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist lixisenatide (Lyxumia(®)) is under development with Sanofi for the treatment of type 2 diabetes mellitus. Lixisenati...

Pomalidomide: First Global Approval.

Pomalidomide (Pomalyst(®)) is a small molecule analogue of thalidomide under development with Celgene Corporation for the oral treatment of haematological and connective tissue diseases. Pomalidomide...

Clinical Trials [ 340 Associated Clinical Trials listed on BioPortfolio]

Effectiveness Study of the International Child Development Program

The objective of this study is to evaluate the effect of the International Child Development Program (ICDP). Research questions to be answered: 1. Does the ICDP affect children's psycho...

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

LCH III is an international, multicentric, prospective clinical study comprised of: - a randomized clinical trial for multisystem "RISK" patients and - a randomized clinical trial...

INTERSALT: International Study of Sodium, Potassium, and Blood Pressure

To coordinate an international study on the relationships between population mean sodium and potassium intake and blood pressure.

The Von Willebrand Disease (VWD) International Prophylaxis Study

The von Willebrand Disease Prophylaxis Network (vWD PN) is an international study group formed with the goal of investigating the role of prophylaxis in clinically severe VWD that is non-r...

International Programs Collaborative Studies Coordinating Center

To continue the work of the Collaborative Studies Coordinating Center (CSCC) on international studies in cardiopulmonary disease epidemiology. The work was being performed under bilateral...

Companies [ 1079 Associated Companies listed on BioPortfolio]

Adis International - USA

Adis provides total communications solutions for the pharmaceutical and related industries. In addition to producing a range of specialized drug information products, Adis works closely with you to pr...

Adis International

Adis provides total communications solutions for the pharmaceutical and related industries. In addition to producing a range of specialized drug information products, Adis works closely with you to pr...

Wolters Kluwer Pharma Solutions, Inc.

Wolters Kluwer Pharma Solutions, Inc. (Bridgewater, NJ) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company's brands include A...

Wolters Kluwer Pharma Solutions

Wolters Kluwer Pharma Solutions, Inc. (Bridgewater, NJ) provides clinical and healthcare data and analytics, leading medical publishing services, and market intelligence tools to professionals in the...

Wolters Kluwer Health Pharma Solutions

Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and t...